• Home
  • About Us
    • Current Funding
    • Team Celebrations >
      • 2024 Celebration
      • 2022 Celebration
      • 2021 Celebration
    • Research Studies >
      • PROTECT-MC
      • STEP >
        • STEP inpatient
      • Completed or Inactive >
        • COPES >
          • COPES-PLUS
        • CHESS
        • P3 Study >
          • P3-FitBit
          • P3-Remote
        • EPOCH
        • RESET
        • STEP outpatient
  • Science
    • SMFM 2025 >
      • SMFM2025_vag_cytokines_ptb
      • SMFM2025_stress_resil_oral
      • SMFM2025_neighborhood
      • SMFM2025_prolonged_latent_labor
      • SMFM2025_allo_ptb
      • SMFM2025_sleep_PTB
      • SMFM2025_Racism_plac_comps
    • Prior Meetings >
      • SMFM 2024 >
        • SMFM2024_inbody_hdop
        • smfm2024_inbody_comp
        • SMFM2024 - PA and SPTB
        • SMFM2024 - PA and Ante
        • SMFM2024 - PA and CI
      • SRI 2023
      • SMFM 2023
      • SMFM 2022
      • SMFM 2021
      • SMFM 2020
  • Patients
    • Support resources
  • News
  • Libby&Lucy Overman
  • Contact
  • CARE Program
Prematurity Prevention
  • Home
  • About Us
    • Current Funding
    • Team Celebrations >
      • 2024 Celebration
      • 2022 Celebration
      • 2021 Celebration
    • Research Studies >
      • PROTECT-MC
      • STEP >
        • STEP inpatient
      • Completed or Inactive >
        • COPES >
          • COPES-PLUS
        • CHESS
        • P3 Study >
          • P3-FitBit
          • P3-Remote
        • EPOCH
        • RESET
        • STEP outpatient
  • Science
    • SMFM 2025 >
      • SMFM2025_vag_cytokines_ptb
      • SMFM2025_stress_resil_oral
      • SMFM2025_neighborhood
      • SMFM2025_prolonged_latent_labor
      • SMFM2025_allo_ptb
      • SMFM2025_sleep_PTB
      • SMFM2025_Racism_plac_comps
    • Prior Meetings >
      • SMFM 2024 >
        • SMFM2024_inbody_hdop
        • smfm2024_inbody_comp
        • SMFM2024 - PA and SPTB
        • SMFM2024 - PA and Ante
        • SMFM2024 - PA and CI
      • SRI 2023
      • SMFM 2023
      • SMFM 2022
      • SMFM 2021
      • SMFM 2020
  • Patients
    • Support resources
  • News
  • Libby&Lucy Overman
  • Contact
  • CARE Program

SMFM 2025:
​Stress, Resilience, and
​Adverse Placentally Mediated Outcomes
(presented in oral format in Fellows Plenary)

Picture

Contact the primary author, Maura Jones (current 3rd year UNC MFM Fellow): [email protected]
Abstract as printed in the SMFM 2025 abstract book:

Patterns of perceived and everyday stress, resilience, and adverse placentally mediated outcomes
  
Prenatal stress is common. However, the quantity and type of stress throughout pregnancy remains poorly defined, and the magnitude of the association between stress, resilience, and hypertensive disorders of pregnancy (HDOP) remains poorly understood.
 
Primary analysis of 2 prospective cohorts, 2017-2022. Patients were recruited <28 weeks’ and completed the Perceived Stress Scale (PSS, range 0-40; ‘high’ stress is ≥ 21), Everyday Stress Index (ESI, range 0-60; higher values = higher stress), and the Brief Resilience Scale (BRS, range 1-5; ‘low’ resilience is <3) surveys. The primary outcome was plac-comps defined as hypertensive disorders of pregnancy ± birthweight < 10% for GA and sex, ± placental abruption). We evaluated whether survey scores in early pregnancy (<24 weeks) were associated with the eventual development of plac-comps. Linear regression was used to evaluate whether survey results <24 weeks assessing stress (by PSS, ESI, or both) and/or resilience were associated with the eventual development of plac-comps.
 
1,133 individuals met inclusion criteria; 267 (24%) had plac-comps. Cohort characteristics are shown in Table 1. In general, stress, as quantified by the PSS and ESI, tended to decrease with increasing gestational age, while resilience increased (Figure 1). Overall scores were similar for those with and without plac-comps. However, when considering survey results <24 weeks, PSS scores were higher and BRS lower among those who developed plac-comps compared to those who did not. In regression models controlling for CHTN, pre-gestational DM, pre-pregnancy BMI, maternal race, and history of PTB, increased resilience (quantified by BRS <24 weeks) was associated with a reduced odds of plac-comps (aOR 0.73, 95% CI 0.56, 0.95). Neither the stress score was associated with plac-comps in regression models. 
 
Overall, stress decreases and resilience increases throughout gestation. Increased resilience in early pregnancy is associated with reduced placentally-mediated adverse outcomes. 

Picture
Picture

Images from Dr. Jones' presentation!

Picture
Picture
Picture
Picture
Picture
Disclaimer: This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services. 
​Please always use your best judgement and speak with your provider regarding your specific situation, circumstances, and condition. 
  • Home
  • About Us
    • Current Funding
    • Team Celebrations >
      • 2024 Celebration
      • 2022 Celebration
      • 2021 Celebration
    • Research Studies >
      • PROTECT-MC
      • STEP >
        • STEP inpatient
      • Completed or Inactive >
        • COPES >
          • COPES-PLUS
        • CHESS
        • P3 Study >
          • P3-FitBit
          • P3-Remote
        • EPOCH
        • RESET
        • STEP outpatient
  • Science
    • SMFM 2025 >
      • SMFM2025_vag_cytokines_ptb
      • SMFM2025_stress_resil_oral
      • SMFM2025_neighborhood
      • SMFM2025_prolonged_latent_labor
      • SMFM2025_allo_ptb
      • SMFM2025_sleep_PTB
      • SMFM2025_Racism_plac_comps
    • Prior Meetings >
      • SMFM 2024 >
        • SMFM2024_inbody_hdop
        • smfm2024_inbody_comp
        • SMFM2024 - PA and SPTB
        • SMFM2024 - PA and Ante
        • SMFM2024 - PA and CI
      • SRI 2023
      • SMFM 2023
      • SMFM 2022
      • SMFM 2021
      • SMFM 2020
  • Patients
    • Support resources
  • News
  • Libby&Lucy Overman
  • Contact
  • CARE Program